SXTC
Price:
$0.3751
Market Cap:
$1.30M
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and munic...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-01-04
Stock Exchange
NASDAQ
Ticker
SXTC
According to China SXT Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -83.62%. This represents a change of 39.86% compared to the average of -59.79% of the last 4 quarters.
The mean historical ROE of China SXT Pharmaceuticals, Inc. over the last ten years is -10.13%. The current -83.62% ROE has changed 725.34% with respect to the historical average. Over the past ten years (40 quarters), SXTC's ROE was at its highest in in the December 2017 quarter at 33.52%. The ROE was at its lowest in in the September 2023 quarter at -191.01%.
Average
-10.13%
Median
-17.22%
Minimum
-109.43%
Maximum
63.97%
Discovering the peaks and valleys of China SXT Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 235.69%
Maximum Annual ROE = 63.97%
Minimum Annual Increase = -889.69%
Minimum Annual ROE = -109.43%
Year | ROE | Change |
---|---|---|
2024 | -22.24% | -44.94% |
2023 | -40.40% | 15.67% |
2022 | -34.92% | 102.84% |
2021 | -17.22% | -84.27% |
2020 | -109.43% | -889.69% |
2019 | 13.86% | -61.66% |
2018 | 36.14% | -43.50% |
2017 | 63.97% | 235.69% |
The current ROE of China SXT Pharmaceuticals, Inc. (SXTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-32.52%
5-year avg
-44.84%
10-year avg
-10.13%
China SXT Pharmaceuticals, Inc.’s ROE is greater than Akanda Corp. (-753.35%), greater than Petros Pharmaceuticals, Inc. (-122.55%), less than GelStat Corporation (28.58%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), greater than Qilian International Holding Group Limited (-16.24%), greater than PainReform Ltd. (-450.64%), greater than Regencell Bioscience Holdings Limited (-48.12%), less than Procaps Group S.A. (97.17%), greater than Jupiter Wellness, Inc. (-5.81%), greater than Biofrontera Inc. (-324.62%), greater than FSD Pharma Inc. (-94.58%), less than Acorda Therapeutics, Inc. (485.80%), greater than Lucy Scientific Discovery Inc. (-296.96%), less than Shionogi & Co., Ltd. (12.38%), greater than Sunshine Biopharma, Inc. (-17.88%), greater than Alimera Sciences, Inc. (-33.70%), less than Guardion Health Sciences, Inc. (77.24%), greater than China Pharma Holdings, Inc. (-63.93%), greater than Halo Collective Inc. (-165.53%),
Company | ROE | Market cap |
---|---|---|
-753.35% | $2.38M | |
-122.55% | $3.38M | |
28.58% | $247.19K | |
-582.98% | $3.02M | |
-16.24% | $38.68M | |
-450.64% | $1.58M | |
-48.12% | $70.79M | |
97.17% | $178.26M | |
-5.81% | $49.33M | |
-324.62% | $8.06M | |
-94.58% | $66.67K | |
485.80% | $821.03K | |
-296.96% | $906.91K | |
12.38% | $12.18B | |
-17.88% | $5.94M | |
-33.70% | $301.29M | |
77.24% | $4.35M | |
-63.93% | $3.75M | |
-165.53% | $15.08K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China SXT Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China SXT Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is China SXT Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for China SXT Pharmaceuticals, Inc. (SXTC)?
What is the highest ROE for China SXT Pharmaceuticals, Inc. (SXTC)?
What is the 3-year average ROE for China SXT Pharmaceuticals, Inc. (SXTC)?
What is the 5-year average ROE for China SXT Pharmaceuticals, Inc. (SXTC)?
How does the current ROE for China SXT Pharmaceuticals, Inc. (SXTC) compare to its historical average?